Brief: Immutep Says Commercial Manufacturing Of Eftilagimod Alpha At 2000L Scale Granted Authorization For Clinical Trial Use

Immutep

20/09/2023 23:44

Sept 21 (Reuters) - Immutep Ltd  IMM.AX :
    * COMMERCIAL MANUFACTURING OF EFTILAGIMOD ALPHA AT 2000L
SCALE
GRANTED AUTHORIZATION FOR CLINICAL TRIAL USE

Source text for Eikon:  ID:nASX2MJSLB 
Further company coverage:  IMM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))